I see your point, I certainly would be in that camp if it were me. I don't know that the patients know about the safety profile of Brilacidin though, my assumption is that they purposely know very little-perhaps I'm wrong. It is excellent, as we know, but I just think there may be challenges to recruitment for a trial of this nature, not a bad thing, I just think we will be waiting for results a little longer than a lot of people are assuming.